It was important to note that comorbidities (such as hypertension, diabetes, and cardiovascular disease) and concurrent drugs (e.g., diuretics, ACE inhibitors) contribute much more significantly to the adverse events of NSAIDs than CYP2C9 status, as observed in Supplementary Table 10. The gene discussed is CYP2C9; the disease is cardiovascular disorder.